AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitasafe M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Remedy Life Sciences India Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitasafe M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications, such as nephropathy and vision impairment, and may lessen the risk of cardiovascular events. Diabex Duo 50mg/500mg may be administered independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering health status, glucose levels, and concomitant medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed dietary and exercise regimen is crucial for successful diabetes control, as lifestyle significantly impacts glucose regulation. Commonly reported adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when used with insulin or sulfonylureas; therefore, recognizing and managing hypoglycemic episodes is essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions exist; therefore, disclose all current medications to ensure safe usage. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout the treatment period.

Uses of Sitasafe M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitasafe M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitasafe M 50mg/500mg tablets with a meal.

Common Side effects of Sitasafe M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitasafe M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitasafe M 50mg/500mg Tablet with a meal.

How Sitasafe M 50mg/500mg Tablet works:

Sitagliptin and metformin, combined as Sitasafe M 50mg/500mg tablets, offer enhanced blood glucose management. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action results in superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitasafe M 50mg/500mg tablets is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitasafe M 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitasafe M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitasafe M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitasafe M 50mg/500mg tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Use of Sitasafe M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Sitasafe M 50mg/500mg Tablet :

Should you forget a dose of Sitasafe M 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitasafe M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitasafe M 50mg/500mg Tablet

Sitasafe M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitasafe M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Sitasafe M 50mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with allergies to Sitasafe M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitasafe M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin + Metformin (Sitasafe M 50mg/500mg Tablet) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitasafe M and seek immediate medical attention.
Sitasafe M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitasafe M 50mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitasafe M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitasafe M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitasafe M 50mg/500mg) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitasafe M and seek immediate medical attention.
Prolonged use of Sitasafe M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sitasafe M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitasafe M 50mg/500mg tablets may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Sitasafe M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasafe M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitasafe M 50mg/500mg) can rarely cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, older adults, and heavy alcohol users, hence it's avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitasafe M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitasafe M 50mg/500mg Tab...
103
MRP 120
14% off